Clinical Trial Update: Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 trial examining muscarinic receptor antagonists as a therapy for diabetic neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Neuropathy

Drugs mentioned

• Muscarinic receptor antagonists

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Diabetic; Neuropathic, Polyneuropathy (Manifestation) | Phase 3 | Status: COMPLETED